Annual Results Results Snapshot
Figures in Rs cr
Consolidate Annual Results
Mar'24
Net Sales
477.98
Other Operating Income
0.00
Total Operating income
477.98
Raw Material Cost
32.43
Purchase of Finished goods
0.00
(Increase) / Decrease In Stocks
0.00
Employee Cost
37.45
Power Cost
0.00
Manufacturing Expenses
0.00
Selling and Distribution Expenses
0.00
Other Expenses
124.27
Total Expenditure (Excl Depreciation)
194.15
Operating Profit (PBDIT) excl Other Income
283.83
Other Income
16.73
Operating Profit (PBDIT)
300.56
Interest
47.22
Exceptional Items
0.00
Gross Profit (PBDT)
253.34
Depreciation
48.15
Profit Before Tax
205.19
Tax
38.87
Provisions and contingencies
0.00
Profit After Tax
166.32
Extraordinary Items
0.00
Prior Period Expenses
0.00
Other Adjustments
0.00
Net Profit
166.32
Share in Profit of Associates
0.00
Minority Interest
0.00
Other related items
0.00
Consolidated Net Profit
166.32
Equity Capital
10.44
Face Value
10.0
Reserves
0.00
Earnings per share (EPS)
159.31
Diluted Earnings per share
159.25
Operating Profit Margin (Excl OI)
59.38%
Gross Profit Margin
53.0%
PAT Margin
34.8%
Public Share Holdings (%)
0.0%
Pledged Promotor Holding (%)
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2024 is 10.95%
Standalone Net Profit
YoY Growth in year ended Mar 2024 is 26.70%
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2024 is 18.68%
Interest
YoY Growth in year ended Mar 2024 is 13.54%
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2024 has improved from Mar 2023
Compare Annual Results Of Ventive Hospital With
Figures in Rs cr
Consolidate Annual Results
Change(INR)
Change(%)
Net Sales
477.98
1,417.25
-939.27
-66.27%
Other Operating Income
0.00
0.00
0.00
Total Operating income
477.98
1,417.25
-939.27
-66.27%
Raw Material Cost
32.43
105.58
-73.15
-69.28%
Purchase of Finished goods
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
Employee Cost
37.45
194.56
-157.11
-80.75%
Power Cost
0.00
72.02
-72.02
-100.00%
Manufacturing Expenses
0.00
56.76
-56.76
-100.00%
Selling and Distribution Expenses
0.00
-8.51
8.51
100.00%
Other Expenses
124.27
412.25
-287.98
-69.86%
Total Expenditure (Excl Depreciation)
194.15
832.66
-638.51
-76.68%
Operating Profit (PBDIT) excl Other Income
283.83
584.59
-300.76
-51.45%
Other Income
16.73
19.79
-3.06
-15.46%
Operating Profit (PBDIT)
300.56
604.38
-303.82
-50.27%
Interest
47.22
196.66
-149.44
-75.99%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
253.34
407.72
-154.38
-37.86%
Depreciation
48.15
138.37
-90.22
-65.20%
Profit Before Tax
205.19
269.35
-64.16
-23.82%
Tax
38.87
-8.83
47.70
540.20%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
166.32
278.18
-111.86
-40.21%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
166.32
278.18
-111.86
-40.21%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
0.00
-0.02
0.02
100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
166.32
278.17
-111.85
-40.21%
Equity Capital
10.44
205.47
-195.03
-94.92%
Face Value
10.00
10.00
0.00
Reserves
0.00
1,645.87
-1,645.87
-100.00%
Earnings per share (EPS)
159.31
13.54
145.77
1,076.59%
Diluted Earnings per share
159.25
13.53
145.72
1,077.01%
Operating Profit Margin (Excl OI)
59.38%
41.25%
0.00
18.13%
Gross Profit Margin
53.00%
28.77%
0.00
24.23%
PAT Margin
34.80%
19.63%
0.00
15.17%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 477.98 Cr
in Mar 2024Figures in Rs Cr
Annual - Standalone Net Profit
Standalone Net Profit 166.32 Cr
in Mar 2024Figures in Rs Cr
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 283.83 Cr
in Mar 2024Figures in Rs Cr
Annual - Interest
Interest 47.22 Cr
in Mar 2024Figures in Rs Cr
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 59.38%
in Mar 2024Figures in Rs %
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
